A Study to Evaluate Software On Cross-sectional Imaging Evaluation of Microwave-ablated Liver Tumors

Overview

About this study

The primary purpose of this study is to assess the accuracy of the Philips High Precision 3D Ablation Solution software on cross-sectional imaging evaluation of microwave-ablated liver tumors, and to determine whether software accuracy varies based on patient, tumor, and technical procedural factors.

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.

Inclusion Criteria:

  • Patients that are undergoing liver tumor treatment with microwave ablation therapy.

Exclusion Criteria: 

  • Pregnant women.
  • The liver tumor cannot be easily identified on a contrast-enhanced CT scan.
  • There are contraindications to the use of contrast required in the study.
  • Treatment of 4 or more liver tumors.

 

 

Participating Mayo Clinic locations

Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.

Mayo Clinic Location Status Contact

Rochester, Minn.

Mayo Clinic principal investigator

Matthew Callstrom, M.D., Ph.D.

Open for enrollment

Contact information:

Desirae Howe-Clayton

(507) 255-0111

Howe.Desirae@mayo.edu

More information

Publications

Publications are currently not available

Study Results Summary

Not yet available

Supplemental Study Information

Not yet available

.
CLS-20463719

Mayo Clinic Footer